Daily feed · SEC Form 4 filings
Insider buying in low-priced stocks — Sep 20, 2018
Open-market purchases where the filing’s own weighted average price is under $5. Price comes from the Form 4 itself, not a market quote.
| Trade | Reported (ET) | Company | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 18, 2018 PForm 4 → | Sep 19, 8:24 pm EDT | SECOND SIGHT MEDICAL PRODUCTS INCEYES | Gregg WilliamsDirector, 10% Owner | 29,616 | $1.82 | $53,904 | 30,283,736 | +0.10% | plan? |
| Sep 19, 2018 PForm 4 → | Sep 20, 1:08 pm EDT | SOPHIRIS BIO INC.SPHS | Randall E WoodsPresident & Chief Exec Officer, Director | 10,000 | $2.63 | $26,339 | 10,000 | — | plan? |
| Sep 19, 2018 PForm 4/A → | Sep 20, 1:31 pm EDT | SOPHIRIS BIO INC.SPHS | Randall E WoodsPresident & Chief Exec Officer, Director | 10,000 | $2.63 | $26,339 | 10,000 | — | plan? |
| Sep 14, 2018 PForm 4 → | Sep 20, 12:16 pm EDT | ENDONOVO THERAPEUTICS, INC.ENDV | Michael Scott MannPresident, 10% Owner | 12,000 | $0.043 | $516 | 25,928,798 | +0.05% | plan? late |
| Sep 18, 2018 PForm 4 → | Sep 19, 5:39 pm EDT | AMARILLO BIOSCIENCES INCAMAR | Stephen T ChenPresident,Chairman & CEO, Director, 10% Owner | 1,000 | $0.33 | $330 | 424,000 | +0.24% | plan? |
A trading day runs to 4:00 pm ET; filings accepted later appear on the next trading day. Rows aggregate a filing’s matching transaction lines — see the methodology for the exact roll-up rules.